Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

The following is a summary of “A systematic review and meta-analysis of the response to placebo in clinical trials of ...

Autoimmune diseases make the immune system attack healthy tissues. These can affect organs like kidneys, leading to ...

Neurodegenerative diseases are a heterogeneous group of disorders that are characterized by the progressive degeneration of the structure and function of the central nervous system or peripheral ...

An expert in connective tissue disease–associated interstitial lung disease described best approaches for rheumatologists to be proactive in screening, diagnosing, treating, and monitoring patients.

Objectives To evaluate the effectiveness and safety of upadacitinib in treatment-refractory inflammatory myositis. Methods Patients with refractory inflammatory myositis treated with upadacitinib from ...

Objectives Myositis is a heterogeneous family of diseases including dermatomyositis (DM), immune-mediated necrotising myopathy (IMNM), antisynthetase syndrome (AS) and inclusion body myositis (IBM).

We Care for Rare Summit: Celebrating Myositis Science and Patient Stories on Rare Disease Day Rare Disease Day Summit highlights myositis and the 7000 other rare diseases affecting one in ten American ...

What is the difference between arthritis and other rheumatic diseases? Arthritis is a group of more than 100 diseases. It is also a type of rheumatic disease. Rheumatic diseases may cause pain, ...

We developed an endothelial cell-specific polygenic risk score for coronary artery disease (CAD), which quantifies a currently immeasurable axis of CAD risk. This tool identifies patients who are ...